WARREN, N.J. (AP) — WARREN, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $99.2 million in its second quarter.
On a per-share basis, the Warren, New Jersey-based company said it had a loss of $1.29. Losses, adjusted for non-recurring costs and amortization costs, came to $1.16 per share.
The results missed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1 per share.
The biopharmaceutical company posted revenue of $186.7 million in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $192.1 million.
PTC Therapeutics expects full-year revenue in the range of $700 million to $750 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
